The Danbury Health and Human Services team is collaborating with the Norwalk Health Department to promote three significant ...

New immunology data for INO-3107 supporting proposed mechanism of action presented at several recent conferences Data showed ability of INO-3107 to induce an antigen-specific cytotoxic T cell response ...

Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone ...

PDS Biotechnology shares declined after it issued an update about a cancer study with a combination of Versamune HPV and pembrolizumab and reported quarterly results. The stock was down 18%, to $2.25, ...

It's long been known HPV can impact women's fertility, but a new study suggests it could be causing some men's struggles too.

I'll then have James and Sean share updates on our COVID, Norovirus and HPV programs respectively. Then Phil will discuss our financial results before we open the call for your questions. When I ...

Cash, cash equivalents and investments: Kronos Bio has $124.9 million in cash, cash equivalents and investments as of September 30, 2024. R&D expenses : Research and development expenses were $12.3 ...

Cervical cancer is the second most prevalent cancer among women in the Philippines. Twelve women die every day, and 7,897 cases diagnosed annually. Although preventable, the country now faces a ...

ANRS on sexualities and sexual health in 2023 reveals trends that reflect developments observed over the past several decades. However, significant changes have emerged since the early 21st century, ...

Andrew Ellsworth, MDPrairie Doc Perspective What do warts, pap smears, cervical cancer, head and neck cancer, and a vaccine all have in common? Three letters:… ...

Should you invest in Bicara Therapeutics Inc? Click for more on BCAX's promising cancer treatment, but proceed with caution ...

Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that key opinion leader (“ KOL ”) collaborators are presenting results ...